ZEO ScientifiX (OTCQB: ZEOX) has announced the expansion of its medical advisory board with the addition of nine physicians and scientific innovators across key disciplines in regenerative and longevity medicine.
The new advisory board members include: Andrea Asseff-Llanes, DDS, board-certified dentist specializing in regenerative dental medicine; Elizabeth Parrish, founder and CEO of closely held BioViva Sciences and a pioneer in gene-based longevity biotechnology; Faryal Farooqi, MD, physician specializing in longevity medicine and metabolic health; Michael Swartzon, MD, board-certified orthopedic sports medicine physician; Mark A. Rosenberg, MD, president and medical director of closely held Advanced Medical Therapeutics and closely held Integrative Cancer Therapeutics; Constantino Mendieta, MD, board-certified plastic surgeon known for innovations in regenerative surgical approaches; Neel Amin, MD, board-certified anesthesiologist and interventional pain medicine specialist and founder of closely held Advanced Relief Institute; David Karli, MD, board-certified orthopedic surgeon and regenerative medicine researcher; and Jacob Sanchez, CRNA, APRN, founder and CEO of closely held Get Refreshed and certified registered nurse anesthesiologist specializing in aesthetic medicine and provider education.
In a statement, George C. Shapiro, MD, FACC, chief medical officer of ZEO, as well as director and chairman of its advisory board, commented, “Medicine has traditionally focused on treating disease after it appears. Our long-term goal is to better understand and influence the biological systems that drive aging itself. Building a medical advisory board of this caliber reflects ZEO ScientifiX’s commitment to advancing regenerative medicine responsibly and with scientific discipline.”
